Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
James F.T. Li Yim & Donald M. Montgomery. (2011) The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost. Current Medical Research and Opinion 27:8, pages 1499-1502.
Read now
Read now
Konstantin Gugleta. (2010) Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension. Current Medical Research and Opinion 26:6, pages 1255-1267.
Read now
Read now
Makoto Ishikawa & Takeshi Yoshitomi. (2009) Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients. Clinical Ophthalmology 3, pages 493-500.
Read now
Read now
Yoshimi Nakamura, Shusaku Ishikawa, Yuko Nakamura, Hiroshi Sakai, Ichiko Henzan & Shoichi Sawaguchi. (2009) 24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost. Clinical Ophthalmology 3, pages 395-400.
Read now
Read now
Shusaku Ishikawa, Yoshimi Nakamura, Yuko Nakamura, Hiroshi Sakai, Shoichi Sawaguchi, Kazuo Terashima, Makoto Kanno & Hidetoshi Yamashita. (2008) Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study. Clinical Ophthalmology 2:4, pages 703-708.
Read now
Read now
Michele Iester. (2008) Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension. Clinical Ophthalmology 2:3, pages 517-523.
Read now
Read now
Michele Iester. (2008) Brinzolamide. Expert Opinion on Pharmacotherapy 9:4, pages 653-662.
Read now
Read now
Jess T Whitson. (2007) Glaucoma: a review of adjunctive therapy and new management strategies. Expert Opinion on Pharmacotherapy 8:18, pages 3237-3249.
Read now
Read now
Nobuyuki Shoji. (2007) Brinzolamide: efficacy, safety and role in the management of glaucoma. Expert Review of Ophthalmology 2:5, pages 695-704.
Read now
Read now
Articles from other publishers (25)
Maria Francesca Cordeiro, Stefano Gandolfi, Konstantin Gugleta, Eduardo M. Normando & Francesco Oddone. (2023) How latanoprost changed glaucoma management. Acta Ophthalmologica.
Crossref
Crossref
Sapna Sinha, Wesam Shamseldin Shalaby, Wendy W. Liu, Reza Razeghinejad & L. Jay Katz. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
612
661
.
Yara P. Catoira-Boyle, Darrell WuDunn, Louis B. Cantor, John T. Lind, Elizabeth Ann Martin & Steve L. Gerber. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
2331
2399
.
Tao Wang, Linlin Cao, Qikun Jiang & Tianhong Zhang. (2021) Topical Medication Therapy for Glaucoma and Ocular Hypertension. Frontiers in Pharmacology 12.
Crossref
Crossref
Jin A Kim & Heeyoung Lee. (2021) Effectiveness and Safety Verification of Brinzolamide Combination Therapy on Primary Open-angle Glaucoma or Ocular Hypertension: A Systematic Review and Meta-analysis Study. Korean Journal of Clinical Pharmacy 31:3, pages 205-215.
Crossref
Crossref
Yara P. Catoira-Boyle, Darrell WuDunn, Louis B. Cantor, John T. Lind, Elizabeth Ann Martin & Steve L. Gerber. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
69
.
Yuanzhi Liu, Junyi Zhao, Xiaoyan Zhong, Qiming Wei & Yilan Huang. (2019) Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 10.
Crossref
Crossref
Junyi Chen & Xinghuai Sun. 2019. Medical Treatment of Glaucoma. Medical Treatment of Glaucoma
137
145
.
Gábor Holló. 2015. Glaucoma. Glaucoma
559
565
.
Abhijeet Yadav, Vishnu Gupta, Harinder Singh Sethi, Ajay Kumar & Sandeep Kumar. (2014) A COMPARATIVE STUDY OF THE EFFICACY AND ADVERSE EVENT PROFILE OF TOPICAL BRINZOLAMIDE WITH TOPICAL DORZOLAMIDE MONOTHERAPY IN PATIENTS OF PRIMARY OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION IN A NORTH-INDIAN POPULATION. Journal of Evolution of Medical and Dental Sciences 3:38, pages 9806-9819.
Crossref
Crossref
Florent Aptel, Christophe Chiquet & Jean-Paul Romanet. (2012) Intraocular Pressure-Lowering Combination Therapies with Prostaglandin Analogues. Drugs 72:10, pages 1355-1371.
Crossref
Crossref
Norbert Pfeiffer. (2011) Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension. Graefe's Archive for Clinical and Experimental Ophthalmology 249:7, pages 1065-1071.
Crossref
Crossref
Nikola Babic, Veljko Andreic, Aleksandar Miljkovic, Vladimir Canadanovic & Sava Barisic. (2011) Adjunctive therapy with brinzolamide in patients on travoprost treatment. Medicinski pregled Medical review 64:5-6, pages 310-314.
Crossref
Crossref
Jess T. Whitson. 2010. The Glaucoma Book. The Glaucoma Book
629
641
.
Marla B. Sultan, Steven L. Mansberger & Paul P. Lee. (2009) Understanding the Importance of IOP Variables in Glaucoma: A Systematic Review. Survey of Ophthalmology 54:6, pages 643-662.
Crossref
Crossref
Thomas E. Bournias & Jerry Lai. (2009) Brimonidine Tartrate 0.15%, Dorzolamide Hydrochloride 2%, and Brinzolamide 1% Compared as Adjunctive Therapy to Prostaglandin Analogs. Ophthalmology 116:9, pages 1719-1724.
Crossref
Crossref
John H.K. Liu, Felipe A. Medeiros, J. Rigby Slight & Robert N. Weinreb. (2009) Comparing Diurnal and Nocturnal Effects of Brinzolamide and Timolol on Intraocular Pressure in Patients Receiving Latanoprost Monotherapy. Ophthalmology 116:3, pages 449-454.
Crossref
Crossref
Robert L Stamper, Marc F Lieberman & Michael V Drake. 2009. Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. Becker-Shaffer's Diagnosis and Therapy of the Glaucomas
407
419
.
Rania Tabet, William C. Stewart, Robert Feldman & Anastasios G.P. Konstas. (2008) A Review of Additivity to Prostaglandin Analogs: Fixed and Unfixed Combinations. Survey of Ophthalmology 53:6, pages S85-S92.
Crossref
Crossref
Katsuya Miura, Kunio Ito, Chikahiro Okawa, Kota Sugimoto, Koichi Matsunaga & Yukitaka Uji. (2008) Comparison of Ocular Hypotensive Effect and Safety of Brinzolamide and Timolol Added to Latanoprost. Journal of Glaucoma 17:3, pages 233-237.
Crossref
Crossref
Alvaro P. C. Lupinacci, Peter A. Netland, Kenneth H. Fung, David Evans & Yuling Zhao. (2008) Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost. Advances in Therapy 25:3, pages 231-239.
Crossref
Crossref
Louis B. Cantor, Darrell WuDunn, Steve Gerber, Yara Catoira & Robert C. Allen. 2008. Albert & Jakobiec's Principles & Practice of Ophthalmology. Albert & Jakobiec's Principles & Practice of Ophthalmology
2763
2801
.
Robert M. Feldman, Angelo P. Tanna, Ronald L. Gross, Alice Z. Chuang, Laura Baker, Adam Reynolds & Thomas C. Prager. (2007) Comparison of the Ocular Hypotensive Efficacy of Adjunctive Brimonidine 0.15% or Brinzolamide 1% in Combination with Travoprost 0.004%. Ophthalmology 114:7, pages 1248-1254.e2.
Crossref
Crossref
G. Holló, D. Chiselita, N. Petkova, B. Cvenkel, I. Liehneova, B. Izgi, A. Berta, J. Szaflik, E. Turacli & W.C. Stewart. (2018) The Efficacy and Safety of Timolol Maleate versus Brinzolamide Each Given Twice Daily Added to Travoprost in Patients with Ocular Hypertension or Primary Open-Angle Glaucoma. European Journal of Ophthalmology 16:6, pages 816-823.
Crossref
Crossref
Katsuhiko Maruyama & Shiroaki Shirato. (2006) Additive Effect of Dorzolamide or Carteolol to Latanoprost in Primary Open-angle Glaucoma. Journal of Glaucoma 15:4, pages 341-345.
Crossref
Crossref